Chinese Journal of Antituberculosis ›› 2026, Vol. 48 ›› Issue (6): 760-768.doi: 10.19982/j.issn.1000-6621.20250441
• Original Articles • Previous Articles Next Articles
Xu Yong1, Zhou Teng2(
), Liu Junjia1
Received:2025-11-12
Online:2026-06-10
Published:2026-05-25
Contact:
Zhou Teng
E-mail:396103272@qq.com
Supported by:CLC Number:
Xu Yong, Zhou Teng, Liu Junjia. Construction and validation of a risk prediction model for restenosis after interventional treatment of tuberculous airway stenosis[J]. Chinese Journal of Antituberculosis, 2026, 48(6): 760-768. doi: 10.19982/j.issn.1000-6621.20250441
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20250441
| 特征 | 建模组(280例) | 验证组(70例) | 统计检验值 | P值 | ||||
|---|---|---|---|---|---|---|---|---|
| 再狭窄[例(构成比,%)] | χ2=0.106 | 0.745 | ||||||
| 否 | 162(57.86) | 42(60.00) | ||||||
| 是 | 118(42.14) | 28(40.00) | ||||||
| 性别[例(构成比,%)] | χ2=0.004 | 0.951 | ||||||
| 男性 | 73(26.07) | 18(25.71) | ||||||
| 女性 | 207(73.93) | 52(74.29) | ||||||
| 年龄(岁, | 49.84±14.58 | 49.30±15.35 | t=0.272 | 0.786 | ||||
| BMI(kg/m2, | 21.53±2.90 | 21.37±2.73 | t=0.410 | 0.682 | ||||
| 病程(月, | 4.94±1.98 | 5.40±1.80 | t=-1.784 | 0.075 | ||||
| 并发症[例(构成比,%)] | ||||||||
| 高血压 | 31(11.07) | 7(10.00) | χ2=0.066 | 0.797 | ||||
| 糖尿病 | 33(11.79) | 9(12.86) | χ2=0.061 | 0.805 | ||||
| 胸腔积液 | 34(12.14) | 8(11.43) | χ2=0.027 | 0.869 | ||||
| 肺不张 | 59(21.07) | 16(22.86) | χ2=0.106 | 0.745 | ||||
| 治疗分类[例(构成比,%)] | χ2=0.198 | 0.656 | ||||||
| 初治 | 253(90.36) | 62(88.57) | ||||||
| 复治 | 27(9.64) | 8(11.43) | ||||||
| 治疗周期[例(构成比,%)] | χ2=0.027 | 0.870 | ||||||
| 单个 | 113(40.36) | 29(41.43) | ||||||
| 多个 | 167(59.64) | 41(58.57) | ||||||
| 镜下分期[例(构成比,%)] | χ2=0.033 | 0.855 | ||||||
| 非活动期 | 73(26.07) | 19(27.14) | ||||||
| 活动期 | 207(73.93) | 51(72.86) | ||||||
| 气道狭窄部位[例(构成比,%)] | χ2=0.016 | 0.992 | ||||||
| 左侧 | 129(46.07) | 32(45.71) | ||||||
| 右侧 | 126(45.00) | 32(45.71) | ||||||
| 双侧 | 25(8.93) | 6(8.57) | ||||||
| 狭窄程度[例(构成比,%)] | χ2=0.003 | 0.957 | ||||||
| 非重度 | 147(52.50) | 37(52.86) | ||||||
| 重度 | 133(47.50) | 33(47.14) | ||||||
| 狭窄长度[例(构成比,%)] | χ2=0.076 | 0.782 | ||||||
| ≤3cm | 177(63.21) | 43(61.43) | ||||||
| >3cm | 103(36.79) | 27(38.57) | ||||||
| 治疗前全身抗结核治疗[例(构成比,%)] | χ2=0.169 | 0.681 | ||||||
| 否 | 199(71.07) | 48(68.57) | ||||||
| 是 | 81(28.93) | 22(31.43) | ||||||
| 联合治疗方案[例(率,%)] | ||||||||
| 球囊扩张术 | 42(15.00) | 10(14.29) | χ2=0.023 | 0.881 | ||||
| 激光治疗 | 37(13.21) | 9(12.86) | χ2=0.006 | 0.937 | ||||
| 冷冻治疗 | 25(8.93) | 6(8.57) | χ2=0.009 | 0.925 | ||||
| 器官分泌物抗酸染色[例(构成比,%)] | χ2=0.183 | 0.669 | ||||||
| 阴性 | 148(52.86) | 35(50.00) | ||||||
| 阳性 | 132(47.14) | 35(50.00) | ||||||
| 实验室指标 | ||||||||
| Scr(μmol/L, | 56.87±11.91 | 56.27±13.76 | t=0.366 | 0.714 | ||||
| UA(μmol/L, | 309.53±130.22 | 305.82±132.87 | t=0.212 | 0.832 | ||||
| ALB(g/L, | 42.47±4.87 | 42.52±4.75 | t=-0.086 | 0.931 | ||||
| TC(mmol/L, | 4.03±1.00 | 3.96±0.90 | t=0.544 | 0.587 | ||||
| TG(mmol/L, | 1.06±0.32 | 1.06±0.35 | t=-0.107 | 0.915 | ||||
| HDL-C(mmol/L, | 1.14±0.36 | 1.17±0.35 | t=-0.484 | 0.629 | ||||
| LDL-C(mmol/L, | 2.42±0.79 | 2.41±0.80 | t=0.146 | 0.884 | ||||
| GLU(mmol/L, | 5.27±0.85 | 5.33±0.79 | t=-0.536 | 0.593 | ||||
| SII(×109/L, | 797.83±168.88 | 807.69±188.45 | t=-0.427 | 0.670 | ||||
| 自变量 | β值 | s | Wald χ2值 | P值 | OR值 | 95%CI值 | |
|---|---|---|---|---|---|---|---|
| 下限 | 上限 | ||||||
| 并发高血压 | 0.782 | 0.528 | 2.188 | 0.139 | 2.185 | 0.776 | 6.153 |
| 并发糖尿病 | 1.140 | 0.573 | 3.960 | 0.047 | 3.126 | 1.017 | 9.604 |
| 镜下分期为活动期 | 0.973 | 0.405 | 5.781 | 0.016 | 2.646 | 1.197 | 5.851 |
| 狭窄长度>3cm | 1.693 | 0.361 | 22.060 | <0.001 | 5.437 | 2.682 | 11.022 |
| 治疗前行全身抗结核治疗 | -1.122 | 0.396 | 8.042 | 0.005 | 0.326 | 0.150 | 0.707 |
| 进行球囊扩张术 | -0.631 | 0.494 | 1.628 | 0.202 | 0.532 | 0.202 | 1.402 |
| 器官分泌物抗酸染色阳性 | 0.504 | 0.337 | 2.243 | 0.134 | 1.656 | 0.856 | 3.203 |
| TG | 0.466 | 0.547 | 0.726 | 0.394 | 1.594 | 0.546 | 4.658 |
| HDL-C | -0.883 | 0.476 | 3.436 | 0.064 | 0.414 | 0.163 | 1.052 |
| SII升高 | 0.008 | 0.001 | 40.581 | <0.001 | 1.008 | 1.006 | 1.011 |
| 常量 | -7.940 | 1.311 | 36.694 | <0.001 | 0.000 | ||
| [1] | Chen Q, Huang T, Zou L, et al. Differences in epidemiological and clinical features between adult and pediatric tracheobronchial tuberculosis patients in Southwest China. Front Public Health, 2023, 11: 1225267. doi:10.3389/fpubh.2023.1225267. |
| [2] | Su Z, Cheng Y, Wu Z, et al. Incidence and Predictors of Tracheobronchial Tuberculosis in Pulmonary Tuberculosis: A Multicentre, Large-Scale and Prospective Study in Southern China. Respiration, 2019, 97(2): 153-159. doi:10.1159/000492335. |
| [3] | Peng AZ, Yang A, Li SJ, et al. Incidence, laboratory diagnosis and predictors of tracheobronchial tuberculosis in patients with pulmonary tuberculosis in Chongqing, China. Exp Ther Med, 2020, 20(6): 174. doi:10.3892/etm.2020.9304. |
| [4] | 陈善婷, 郭述良. 支气管结核性气道狭窄介入治疗研究进展. 职业与健康, 2016, 32(3): 419-422. doi:10.13329/j.cnki.zyyjk.2016.0187. |
| [5] | Li F, Tian S, Huang H, et al. Post-tuberculosis tracheobronchial stenosis: long-term follow-up after self-expandable metallic stents placement and development of a prediction score-the Restenosis Score. Eur J Med Res, 2022, 27(1): 133. doi:10.1186/s40001-022-00765-1. |
| [6] | 中华医学会结核病学分会, 《中华结核和呼吸杂志》编辑委员会. 气管支气管结核诊断和治疗指南(试行). 中华结核和呼吸杂志, 2012, 35(8): 581-587. doi:10.3760/cma.j.issn.1001-0939.2012.08.007. |
| [7] | World Medical Association. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Participants. JAMA, 2025, 333(1): 71-74. doi:10.1001/jama.2024.21972. |
| [8] | 曾宗鼎, 苏柱泉, 孙婉, 等. 插管后气管狭窄介入治疗的疗效及其影响因素分析. 中国呼吸与危重监护杂志, 2017, 16(4): 367-370. doi:10.7507/1671-6205.201703034. |
| [9] | 杨东明, 许东风, 任蔚, 等. 冷热联合消融技术治疗气道良性肿瘤效果及预后影响因素分析. 现代肿瘤医学, 2024, 32(2): 276-280. doi:10.3969/j.issn.1672-4992.2024.02.013. |
| [10] | Huang W, Xu C, Wei B, et al. Analysis of Risk Factors for Restenosis after Interventional Treatment of Tuberculous Airway Stenosis. Respiration, 2025, 104(5): 341-348. doi:10.1159/000542909. |
| [11] | 罗莉, 周磊, 罗林紫, 等. 球囊扩张联合曲安奈德局部注射治疗结核性气管支气管狭窄的疗效及相关机制探讨. 临床肺科杂志, 2024, 29(9): 1297-1303. doi:10.3969/j.issn.1009-6663.2024.09.001. |
| [12] | Alwin Robert A, Al Dawish MA. Microvascular complications among patients with diabetes: An emerging health problem in Saudi Arabia. Diab Vasc Dis Res, 2019, 16(3): 227-235. doi:10.1177/1479164118820714. |
| [13] | Hu T, Li Y, Wang X, et al. Early and Regular Bronchoscopy Examination on Effect of Diagnosis and Prognosis for Patients With Tracheobronchial Tuberculosis. Front Med (Lausanne), 2022, 9: 825736. doi:10.3389/fmed.2022.825736. |
| [14] | Liew PX, Kubes P. The Neutrophil’s Role During Health and Disease. Physiol Rev, 2019, 99(2): 1223-1248. doi:10.1152/physrev.00012.2018. |
| [15] | Yin LX, Motz KM, Samad I, et al. Fibroblasts in Hypoxic Conditions Mimic Laryngotracheal Stenosis. Otolaryngol Head Neck Surg, 2017, 156(5): 886-892. doi:10.1177/0194599817697049. |
| [16] | Le TT, Karmouty-Quintana H, Melicoff E, et al. Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis. J Immunol, 2014, 193(7): 3755-3768. doi:10.4049/jimmunol.1302470. |
| [17] | Motz KM, Yin LX, Samad I, et al. Quantification of Inflammatory Markers in Laryngotracheal Stenosis. Otolaryngol Head Neck Surg, 2017, 157(3): 466-472. doi:10.1177/0194599817706930. |
| [18] | Li CY, Xie RX, Zhang SW, et al. Metabolism, fibrosis, and apoptosis: The effect of lipids and their derivatives on keloid formation. Int Wound J, 2024, 21(2): e14733. doi:10.1111/iwj.14733. |
| [1] | Reyhangul·Aken , Muratjan·Amat , Gao Xusheng, Ding Caihong, Zeng Yi, Chen Yu, Bai Yan, Fan Lin. Analysis of influencing factors of malnutrition and treatment outcomes among elderly patients with pulmonary tuberculosis aged 60 years and above [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 751-759. |
| [2] | Jiangxi Chest Hospital/Jiangxi Provincial Key Laboratory of Tuberculosis, Chinese Antituberculosis Association, Guangzhou National Laboratory. Expert consensus on the diagnosis and treatment of breast tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 737-750. |
| [3] | Fan Jiahua, Yan Liang, Chen Hua, Lu Chunli, Wang Min, Huang Yaling, Li Yan. Association between nutritional risk, inflammatory indicators, and glycemic control in patients with tuberculosis complicated by diabetes mellitus [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 769-778. |
| [4] | Wang Xinyan, Pan Hongfang, Mei Xue, Zhang Yi, Liu Jie. Analysis of the characteristics of peripheral blood clinical detection indicators in patients with pulmonary tuberculosis complicated with osteoarticular tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 779-786. |
| [5] | Li Jing, Chen Shuangshuang, Chen Chunhua, Yang Guoxiang, Yang Chengnao, Zheng Luyun, Tan Chengjian, Li Chuanyou, Li Jie, Zhou Peifu, Dai Xiaowei. Screening of anti-tuberculosis activity and analysis of chemical constituents of the Ethnomedicine Botrychium ternatum [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 787-794. |
| [6] | Xia Lu, Mu Tingting, Cai Qiujie, Ma Yan, Gong Mengmeng, Ye Dan, Zhang Wei. Analysis of Traditional Chinese Medicine syndrome characteristics in 619 severe pulmonary tuberculosis patients based on syndrome element differentiation [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 795-802. |
| [7] | Guo Chenhao, Liu Xinyu, Zhan Sirui, Wang Lili, Ma Mengting, Li Xiumei, Qi Linping, Li Weiping. Interferon-gamma release assays for diagnosing extrapulmonary tuberculosis in adults: a systematic review and Meta-analysis [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 803-812. |
| [8] | Zhang Yue, Huang Jinpeng, Gao Dan, Ling Lin. Status and influencing factors of medication adherence among elderly tuberculosis patients based on digital technologies [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 813-820. |
| [9] | Zhang Yaying, Wang Senlu, Guliziba Kuerbanjiang, Abulikemu Aili, Liang Chen, Yuan Shuanglong, Li Caihong, Cao Mingqin. Analysis of influencing factors and pathways on psychological burden associated with pulmonary tuberculosis treatment in Southern Xinjiang Region of the Xinjiang Uygur Autonomous Region [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 821-829. |
| [10] | Du Xilong, Maiwulajiang·Yimamu , Na Yan, Paziliya·Yasheng , Guo Gang, Maiweilanjiang·Abulimiti , Zhang Liping, Zheng Yanling. Construction of an optimal prediction model for treatment outcomes in retreatment pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 830-839. |
| [11] | Liu Lin, Yin Xiaocheng, Zhang Xiaofo, Liang Linlong, Yang Ju. Global burden of tuberculosis in children aged 0-14 years, 1990—2023, and trend projections for 2024—2050 [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 840-848. |
| [12] | Huang Aichun, Lan Yanqun, Xu Chaoyan, Zhang Jie, Li Weiwen, Zhu Qingdong, Xie Zhouhua. Analysis of related factors influencing interferon-gamma release assay results in patients having coexistent tuberculosis and acquired immune deficiency syndrome [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 849-855. |
| [13] | Jiang Xuefeng, Zhou Linjun, Sun Yan, Jiang Mingxia, Ma Ling, Mei Li, Liu Dongxin. Analysis of drug resistance gene mutation characteristics in Mycobacterium tuberculosis strains from five northwestern provinces of China [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 856-864. |
| [14] | Yuan Shaoying, Cui Zhongfeng, Du Jiang, Cao Xuefang, Feng Boxuan, He Yijun, Li Zihan, Zhao Yaqi, Yu Yilin, Gao Lei, Xin He’nan, Li Hongzhi. The application value of the QuantiFERON-TB Gold Plus for active pulmonary tuberculosis diagnosis and treatment response monitoring [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 865-873. |
| [15] | Qiao Xiaobo, Li Jing, Wang Baoqian, Zhou Weidong, Wang Fei, Zhang Qibo, Li Tongxia. Study on the diagnostic value of GeneXpert MTB/RIF and BACTEC MGIT 960 in bronchoalveolar lavage fluid combined with peripheral blood IGRA testing for etiologically negative pulmonary tuberculosis diagnosis [J]. Chinese Journal of Antituberculosis, 2026, 48(6): 874-881. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.